Cervical Cancer Clinical Trials

AB598

A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and

Combination Therapy in Participants with Advanced Malignancies

Learn More

CRB-701

A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an

Antibody-drug Conjugate Targeting Nectin-4, in Patients with Advanced Solid Tumors

Learn More